Introduction
============

Next generation sequencing (NGS) technologies allow large-scale sequencing at a very low cost.[@b1-grsb-8-2014-033] Several technologies on the market are competing for producing massive reads at the lowest cost. Some of the well-known technologies are Illumina, Titanium, Applied Biosystems, and Helicos BioScience HeliScope, capable of producing a million reads.[@b2-grsb-8-2014-033] The NGS has revolutionized genetics studies of RNA-Seq for transcriptome analysis and ChIP-Seq for DNA-proteins interaction.[@b2-grsb-8-2014-033] As a result, ChIP-Seq becomes an essential tool for studying gene regulation and gene expression, while RNA-Seq becomes an alternative for studying diseases and mutations.[@b3-grsb-8-2014-033] ChIP-Seq, or chromatin immunoprecipitation followed by sequencing, is a technique for genome-wide annotation of protein and DNA interaction as well as histone modifications. [@b4-grsb-8-2014-033] Unlike its predecessor, ChIP-chip, ChIP-Seq provides higher spatial resolution, dynamic range, and genomic coverage; thus, it has higher sensitivity as well as specificity for protein binding site identification than its predecessor.[@b5-grsb-8-2014-033] Moreover, ChIP-Seq can be utilized for analyzing any species with a sequenced genome, since it is not limited by the availability of an organism-specific microarray.[@b5-grsb-8-2014-033] Because of its advantages for offering higher resolution, less noise, and better coverage, in conjunction with the declining of sequencing cost, ChIP-Seq has grown to be an essential instrument for studying gene regulation as well as epigenetic mechanisms.[@b4-grsb-8-2014-033]

RNA-Seq is the mRNA sequencing technology that provides high-precision measurement for the levels of transcripts and their isoforms.[@b3-grsb-8-2014-033] Thus, it allows the entire transcriptome to be analyzed with a very high-throughput and a quantitative approach.[@b3-grsb-8-2014-033]

In this work, we investigated two histone marks: H3K4me3 and H3K4me1, which have been used for identifying the *cis*-regulatory elements that control the gene expression. The *cis*-regulatory elements are categorized into promoters, enhancers, silencers, and insulators.[@b6-grsb-8-2014-033] H3K4me3 mark has been identified as an active promoter in[@b7-grsb-8-2014-033]--[@b10-grsb-8-2014-033] while H3K4me1 mark has been identified as an enhancer in.[@b7-grsb-8-2014-033],[@b11-grsb-8-2014-033]--[@b14-grsb-8-2014-033] Using the advantages of ChIP-Seq and RNA-Seq, we identified highly expressed genes by histone H3K4me3 or by both histones H3K4me3 and H3K4me1. These highly expressed genes have been found by performing three essential steps. First, we identified the expressed genes from ChIP-Seq. Then, we identified the expressed genes from RNA-Seq. Finally, we compared the expressed genes from ChIP-Seq with the expressed genes from RNA-Seq for identifying highly expressed genes by both.

We also investigated the functional relationship between mouse liver and mouse embryonic stem cell (mESC) by H3K4me3 and by H3K4me1 using ChIP-Seq. The analysis has been performed by comparing the expressed genes in mouse liver with the expressed genes in mESC for identifying the overlapping genes in both and the non-overlapping genes in each tissue. In addition, we identified the non-overlapping genes in RNA-Seq for mouse liver and for mESC, and verified them using the public Ensemble gene database from NCBI.[@b15-grsb-8-2014-033] The verification uncovered the novel genes in RNA-Seq for mouse liver and for mESC. We also further identified the expressed genes in RNA-Seq for liver and for mESC.

Methods
=======

Tools
-----

Our experiments have been performed on a cluster machine and on a PC that has 2 GB of RAM and a 2.19 GHZ processor. The cluster machine has 1 head node and 23 compute nodes. Each node has 24 GB of RAM and 24 2.66 GHZ processors. All experiments have been performed on a single node of the cluster. We used Model-based Analysis of ChIP-Seq (MACS) version 1.4 for identifying the binding sites in ChIP-Seq. [@b16-grsb-8-2014-033] MACS uses a dynamic Poisson distribution to calculate the peaks for identifying the binding sites.[@b16-grsb-8-2014-033] The reason we used MACS is that it provides the largest number of peaks compared to other tools, and offers high sensitivity and accuracy for peak detection.[@b17-grsb-8-2014-033] We employed TopHat version 2.0.8 for identifying the splice junctions in RNA-Seq because of its speed efficiency.[@b18-grsb-8-2014-033] We exploited the multi-threaded option in TopHat for utilizing 24 processors within the node. TopHat is a fast read-mapping algorithm, which uses the ultrafast Bowtie aligner for aligning reads from RNA-Seq to the reference genome.[@b18-grsb-8-2014-033] We used Cufflinks version 2.0.2 for obtaining the genes and their transcript abundances from RNA-Seq.[@b19-grsb-8-2014-033] Cufflinks assembles aligned transcripts from TopHat and estimates their abundances using Fragments Per Kilobase of transcript per Million fragments mapped (FPKM).[@b19-grsb-8-2014-033],[@b20-grsb-8-2014-033] We employed Cufflinks as it provides the maximum precision for estimating transcript abundances.[@b21-grsb-8-2014-033] Again, we took advantage of the multi-threaded option in Cufflinks for utilizing 24 processors within the node. MACS, TopHat, and Cufflinks are open-source software. MACS is only available for Linux, while TopHat and Cufflinks are available for both Mac OS and Linux. MACS, TopHat, and Cufflinks were installed on the cluster machine. We used ChIPpeakAnno version 2.8.0,[@b22-grsb-8-2014-033] which is available from Bioconductor, for identifying nearby genes from the peaks obtained from MACS. ChIPpeakAnno is written in R language and can be installed from R. We employed ChIPpeakAnno because of its ease of use for obtaining nearby genes. ChIPpeakAnno was installed on a laptop PC for our experiments. We used Microsoft Access 2007 for storing the results and reference files. We implemented SQL language for our comparison and analysis.

Datasets
--------

The procedure for preparing the mouse liver and mESC datasets described by Shen et al. has been followed in this study.[@b23-grsb-8-2014-033] Mouse liver tissue has been harvested from 8-week adult male C57Bl/6 mice. Mouse ESCs have been extracted from E14.5 C57Bl/6 mouse embryos. The tissues were minced to fine pieces and prepared for sequencing. The ChIP-Seq sequencing has been carried out on Illumina Genome Analyzer II with 500 μg chromatin and 5 μg antibody. The antibodies used for the datasets in our ChIP-Seq experiment was H3K4me3 (Millipore 05--745) and H3K4me1 (Abcam, ab8895). RNA sequencing has been performed on Illumina Genome Analyzer II using RNA sample tissues that have been extracted from Trizol^®^ according to protocol (Invitrogen). The polyA+RNA have been purified with the Dynabeads mRNA purification kit (Invitrogen).[@b23-grsb-8-2014-033]

The undifferentiated E14 mESCs have been cultured under feeder-free conditions, as described by Xiao et al.,[@b24-grsb-8-2014-033] and guided differentiation has also been carried out. The antibodies used for the datasets in our ChIP-Seq experiment are H3K4me1 antibody, ChIP Grade ab8895, and H3K4me3 antibody, ChIP Grade ab1012. The ChIP-Seq sequencing has been performed on Illumina Genome Analyzer II and the sequence reads were obtained and mapped to reference genomes mm9.[@b24-grsb-8-2014-033]

In our ChIP-Seq experiment, we used two mouse liver datasets, GEO: GSM722761 and GEO: GSM722760, for H3K4me3 and H3K4me1 respectively, from Shen et al.[@b23-grsb-8-2014-033] Each dataset contains two files in bam format that have been aligned with the mouse genome mm9 on Illumina. For the RNA-Seq experiment, we used one mouse liver dataset (GEO: GSM723772) and one mESC dataset (GEO: GSM723776) from Shen et al.[@b23-grsb-8-2014-033] The liver dataset contains two files SRR207100 and SRR207101 in Sequence Read Archive (SRA) format.[@b23-grsb-8-2014-033] The SRA files have been converted to fastq format using SRA Toolkit for running TopHat.[@b18-grsb-8-2014-033],[@b25-grsb-8-2014-033] The mESC dataset also contains two files, SRR207108 and SRR207109, in SRA format, were also converted to fastq format for running TopHat.[@b18-grsb-8-2014-033],[@b23-grsb-8-2014-033] Shen et al. produced two files, to ensure that their datasets would be reproducible. Thus, we used both files in their datasets and combined the unique results from both.[@b23-grsb-8-2014-033]

We also utilized six mESC ChIP-Seq datasets from Xiao et al,[@b24-grsb-8-2014-033] for comparing with the results from ChIP-Seq for liver. Three datasets were used for histone H3K4me1: GEO: GSM881352, GEO: GSM881360, and GEO: GSM881369, for mESC E14 day 0, day 4, and day 6 respectively. Three other datasets, for histone H3K4me3, were: GEO: GSM881354, GEO: GSM881362, and GEO: GSM881371 for mESC E14 day 0, day 4, and day 6 respectively.[@b24-grsb-8-2014-033]

Design
------

Our experimental design contains seven experiments. The purpose of conducting these individual experiments is that it allowed us to identify highly expressed genes by promoter H3K4me3 or by both promoter H3K4me3 and enhancer H3K4me1 using different filters. It allowed us to identify the genes that carry liver functions and the genes that carry mESC functions as well as the genes that carry common functions from both. It also uncovered the genes in RNA-Seq for liver and the genes in RNA-Seq for mESC that are not presently in the Ensemble gene database at NCBI.

We performed four experiments for comparing genes in ChIP-Seq with genes in RNA-Seq for identifying highly expressed genes by histone H3K4me3 or by both histones H3K4me3 and H3K4me1. In addition, we performed two experiments for comparing genes in mouse liver with genes in mESC for histones H3K4me3 and H3K4me1. Our purpose was to identify genes that perform common functions for liver and mESC, and to identify the unmatched genes in liver and in mESC and investigate their functions using GOStat.[@b26-grsb-8-2014-033] We performed an additional experiment to examine the genes in RNA-Seq for liver and the genes in RNA-Seq for mESC, identifying the genes that are expressed in each tissue. We analyzed the results in each experiment and compared them with the results from other experiments to reinforce our investigations. The details of our experimental design are as follows.

We ran MACS for ChIP-Seq datasets to obtain the output peak files.[@b16-grsb-8-2014-033] These peak files were used to run *annotatePeakInBatch* from ChIPpeakAnno for obtaining nearby genes.[@b22-grsb-8-2014-033] For RNA-Seq, we ran TopHat on two fastq files for identifying the splice junctions and obtaining the aligned mapping results.[@b18-grsb-8-2014-033] We ran Cufflinks on the aligned mapping files using the gene transcript file, version mm9, for identifying gene symbols as well as gene expression based on FPKM value.[@b19-grsb-8-2014-033],[@b20-grsb-8-2014-033]

We compared the genes found from ChIP-Seq with the genes found from RNA-Seq for obtaining the overlapping and non-overlapping genes. These overlapping and non-overlapping genes have been confirmed with the Ensemble gene reference from NCBI.[@b15-grsb-8-2014-033] We also performed Gene Ontology (GO) analysis on these genes.[@b27-grsb-8-2014-033] [Figure 1](#f1-grsb-8-2014-033){ref-type="fig"} depicts our workflow. We further compared the overlapping genes from ChIP-Seq with genes in six mESC datasets from Xiao et al.[@b24-grsb-8-2014-033] We used tables in a database for storing the output files, and used SQL language for finding the overlapping and non-overlapping genes. Also, the Ensemble gene references *EnsGene*, downloaded from UCSC Genome Browser,[@b28-grsb-8-2014-033] and *gene*2*ensembl*, downloaded from NCBI,[@b15-grsb-8-2014-033] have been stored in the database for matching and checking the results against the references. Settings for the individual experiments have been designed as follows.

### Experiment 1

To perform our ChIP-Seq experiment, we ran MACS on each file in the dataset for H3K4me3 and used the output peak file in bed format for running *annotatePeakInBatch* to get the nearby genes for each file. Subsequently, we ran *getEnrichedGO* from ChIPpeakAnno on each output-annotated file from *annotatePeakInBatch* to get the GOStat for each file.[@b22-grsb-8-2014-033],[@b26-grsb-8-2014-033] We imported the output files containing nearby genes to the database and used SQL language for the subsequent steps. We filtered each file to get nearby genes with distance ≤2 kb from the start of the peak to transcription start site (TSS) for both positive strand and negative strand. The gene symbols for the Ensemble genes in each file were obtained by matching them with the *EnsGene* reference from UCSC.[@b28-grsb-8-2014-033] We also acquired the Entrez ID for the genes in each file by matching them with the *gene*2*ensembl* reference from NCBI.[@b15-grsb-8-2014-033] Subsequently, the nearby genes from both files were combined into a unique list without duplicates.

To perform our RNA-Seq experiment, we ran TopHat on both fastq files and obtained the output splice junction files. These output files were used to run Cufflinks for acquiring two output transcripts files. We imported both output files from Cufflinks to the database and applied three different filters on each file to get a set of genes for each filter.

-   Filter 1: used average FPKM (for FPKM ≥ 0)

    We obtained the average FPKM value for all the genes having FPKM ≥ 0 and used this average as a threshold for selecting a set of genes that have FPKM ≥ threshold. Thus, about 50% of the genes in each file were selected.

-   Filter 2: used all FPKM (for FPKM ≥ 0)

    We selected all the genes in each file that have FPKM ≥ 0. Thus, 100% of the genes in each file were selected.

-   Filter 3: used ¾ (for FPKM ≥ 0)

    We sorted the whole file by FPKM value in descending order and selected ¾ of the file from the top down. Thus, 75% of the genes in each file were selected.

For each filter, the genes from both files were combined into a unique list with duplicates removed. Next, the genes found from ChIP-Seq were compared with the genes found from RNA-Seq for each filter. We obtained the overlapping and non-overlapping genes and checked them against the Ensemble gene reference. Lastly, we analyzed the GOStat for the overlapping genes.[@b26-grsb-8-2014-033]

### Experiment 2 co-localization

This experiment consisted of a co-localization between ChIP-Seq for H3K4me3 and ChIP-Seq for H3K4me1. Our purpose was to obtain highly expressed genes from both marks. We followed the same procedure for ChIP-Seq as in Experiment 1 for all files in both datasets, except we used 1 Mb distance as a filter for H3K4me1 to get nearby genes. Since enhancers can be located far away from the TSS, we used a distance of ≤1 Mb for all possible enhancers. This is not the same case for promoter H3K4me3 because the promoter usually locates within 2 kb distance from the TSS. The reason we chose the distance of 1 Mb is that we wanted to make sure that we did not miss possible long range enhancers. In fact, Lettice et al. and Sagai et al. have identified a long range Shh enhancer regulates its target gene in the distance of 1 Mb away.[@b29-grsb-8-2014-033],[@b30-grsb-8-2014-033]

Subsequently, we combined the genes found from the two files in each dataset, H3K4me3 and H3K4me1, into a unique list. Then, we obtained the matched genes between H3K4me3 and H3K4me1. These matched genes were compared with the genes found in RNA-Seq from Experiment 1 using Filter 1 for obtaining the overlapping and non-overlapping genes. We verified the overlapping and non-overlapping genes with the Ensemble gene reference and performed the GOStat analysis on the overlapping genes.[@b26-grsb-8-2014-033]

### Experiment 3

We used the same dataset for H3K4me3 and followed the same procedure as in Experiment 1 for ChIP-Seq. However, we used the distance ≤500 bp as a filter for obtaining nearby genes. Then, the genes found from ChIP-Seq were compared with the genes found from RNA-Seq using only Filter 3 for obtaining the overlapping and non-overlapping genes. Again, we checked these genes against the Ensemble gene reference and performed the GOStat analysis on the overlapping genes.[@b26-grsb-8-2014-033]

### Experiment 4 Co-localization

This experiment was also a co-localization between ChIP-Seq for H3K4me3 and ChIP-Seq for H3K4me1. We followed the same procedure as in Experiment 2 for ChIP-Seq except we used a distance filter ≤500 bp for H3K4me3 to get nearby genes. We obtained the matched genes between H3K4me3 and H3K4me1. These matched genes were compared with genes found in RNA-Seq from Experiment 1, using Filter 1 for acquiring the overlapping and non-overlapping genes. We checked these genes against the Ensemble gene reference and performed the GOStat analysis on the overlapping genes.[@b26-grsb-8-2014-033]

### Experiment 5

We performed gene comparison between ChIP-Seq for H3K4me1 in mouse liver and ChIP-Seq for H3K4me1 in mESC. The dataset for H3K4me1 in liver was the same dataset used in Experiment 2. The datasets for H3K4me1 in mESC were three mESC datasets for H3K4me1 from Xiao et al.[@b24-grsb-8-2014-033] We ran MACS and *annotatePeakInBatch* on all files for each tissue,[@b16-grsb-8-2014-033],[@b22-grsb-8-2014-033] and obtained nearby genes for each file using the distance ≤1 Mb. Subsequently, we ran *getEnrichedGO* to get GOStat for each file.[@b22-grsb-8-2014-033],[@b26-grsb-8-2014-033] For each tissue, the genes in all files were combined into a unique list. We obtained the non-overlapping genes in each tissue and the overlapping genes between them. We also observed the GOStat for both overlapping and non-overlapping genes.[@b26-grsb-8-2014-033]

### Experiment 6

Again we performed gene comparison, this time between ChIP-Seq for H3K4me3 in mouse liver and ChIP-Seq for H3K4me3 in mESC. The dataset for H3K4me3 in liver was the same dataset as used in Experiment 1. The datasets for H3K4me3 in mESC were three mESC datasets for H3K4me3 from Xiao et al.[@b24-grsb-8-2014-033] We ran MACS and *annotatePeakInBatch* on all files for each tissue to get the nearby genes for each file using the distance ≤2 kb.[@b16-grsb-8-2014-033],[@b22-grsb-8-2014-033] Subsequently, we ran *getEnrichedGO* to get GOStat for each file.[@b22-grsb-8-2014-033],[@b26-grsb-8-2014-033] For each tissue, the genes in all files were combined into a unique list. We obtained the non-overlapping genes and overlapping genes between the two tissues. We also examined the GOStat for both overlapping and non-overlapping genes.[@b26-grsb-8-2014-033]

### Experiment 7

In this experiment, we performed gene comparison between RNA-Seq for liver and RNA-Seq for mESC. We used one RNA-Seq dataset for liver and one RNA-Seq dataset for mESC. We identified the expressed genes for each tissue as well as the genes in mESC that are not found in the Ensemble gene reference. We compared the genes in mESC that are not found in the reference with the list of novel genes found in RNA-Seq for liver and identified additional novel genes in RNA-Seq for mESC.

### Comparing results between experiments

We performed three comparisons on the results obtained from different experiments.

Case 1: compare matched genes between Experiment 1 and Experiment 2. We compared the overlapping genes in Experiment 1 using Filter 1 with the overlapping genes in Experiment 2. The comparison was performed in two steps: (1) taking the average FPKM value for the overlapping genes in each experiment, and (2) comparing these two average FPKM values. Since Experiment 2 performs co-localization of H3K4me3 and H3K4me1 marks, we expected that the average FPKM value in Experiment 2 would be higher.

Case 2: compare GOStat in Experiment 5. We used SQL language for comparing the GOStat of unmatched genes in H3K4me1 in liver with the GOStat of unmatched genes in H3K4me1 in mESC.[@b26-grsb-8-2014-033]

Case 3: compare GOStat in Experiment 6. We used the same procedure as in Case 2 for H3K4me3 mark.[@b26-grsb-8-2014-033]

Results and Discussion
======================

Experiment 1
------------

For each filter, we obtained the genes from ChIP-Seq and the genes from RNA-Seq, as well as the overlapping and non-overlapping genes between them. All overlapping genes and all non-overlapping genes in ChIP-Seq were found in the reference. However, a number of non-overlapping genes in RNA-Seq were not found in the reference. We manually checked a number of genes that were not found in the reference on the Entrez Gene website from NCBI. The results showed these genes had reference sequence status of validated, predicted, provisional, or inferred. Some examples are *AI*463170, *BC*020402, *Gm*2083, and *Atp*6*v*0*c-ps*2. These genes also have several related papers. Further insights into these genes need to be investigated individually. Our experimental results showed these genes came from RNA-Seq experiments; thus, they may belong to coding DNA regions or non-coding DNA regions that have been transcribed. In addition, these genes are predicted and reported by other sources such as MGI.[@b31-grsb-8-2014-033] Furthermore, these genes are not identified by any existing Ensemble gene reference in the public database such as NCBI. Thus, from these facts, it is shown that these genes are novel genes. All comparison results in this experiment are in [Table 1](#t1-grsb-8-2014-033){ref-type="table"} and all novel genes found are included in [Additional file 3.xls](#s3-grsb-8-2014-033){ref-type="supplementary-material"}. Also, the examples of GOStat results can be found in [Table 3 in Supplemental Tables.doc](#s7-grsb-8-2014-033){ref-type="supplementary-material"}.[@b26-grsb-8-2014-033]

Using Filter 2, we obtained the nearby genes for ChIP-Seq using 2 kb distance from the peak to TSS. These are the genes expressed by promoter H3K4me3. We also selected all of the genes for RNA-Seq using all FPKM value ≥ 0 as a threshold. The overlapping genes are expressed genes and promoter H3K4me3 supports their expression, but they are not all highly expressed. For non-overlapping genes in ChIP-Seq but not found in RNA-Seq, these are not expressed genes, though their promoters bear H3K4me3 modification. The non-overlapping genes in RNA-Seq but not found in ChIP-Seq are expressed genes but not for histone H3K4me3.

Using Filter 3, we again acquired the nearby genes for ChIP-Seq using the same 2 kb distance from the peak to TSS. These are expressed genes by promoter H3K4me3. We obtained 75% of the genes from RNA-Seq by sorting FPKM value in descending order. The overlapping genes are expressed and promoter H3K4me3 supports their expression, but they are not all highly expressed. The non-overlapping genes in ChIP-Seq but not found in RNA-Seq are not expressed genes or not strongly expressed genes, though their promoters bear H3K4me3 modification. The non-overlapping genes in RNA-Seq but not found in ChIP-Seq are expressed genes but not for histone H3K4me3.

Using Filter 1, we acquired the nearby genes from ChIP-Seq using the same 2 kb distance from the peak to TSS. These are the genes expressed by promoter H3K4me3. This time we acquired the genes from RNA-Seq using the median FPKM value as a threshold. Thus, we selected about 50% of genes that have expression level ≥ average FPKM value. The overlapping genes are expressed genes and promoter H3K4me3 supported their expression. For non-overlapping genes in ChIP-Seq but not found in RNA-Seq, these are not expressed genes or their expression level is not significant, though their promoters bear H3K4me3 modification. On the other hand, the non-overlapping genes in RNA-Seq but not found in ChIP-Seq are expressed genes but not for histone H3K4me3.

We observed the overlapping genes did not drop a lot from Filter 2 to Filter 3. However, they reduced by half from Filter 3 to Filter 1. This indicates that they are strongly expressed genes. Thus, the more we filtered, the less overlapping genes we obtained but the expression level went up. This observation is confirmed in our comparison sections.

To visualize the difference between gene expression and correlation, we included a snapshot of the UCSC genome browser[@b28-grsb-8-2014-033] view of ChIP-Seq and RNA-Seq data in [Additional Figure 5](#s8-grsb-8-2014-033){ref-type="supplementary-material"}. This figure shows the gene *Slc*25*a*47 (solute carrier family 25, member 47) with two tracks (RNA-Seq liver and ChIP-Seq H3K4me3 liver). The height of the peaks in these tracks shows the difference in gene expression. However, there is not much difference in this case for gene *Slc*25*a*47. The correlation in this case is the corresponding expression found in both ChIP-Seq and RNA-Seq data for this gene.

Experiment 2 co-localization
----------------------------

We obtained the matched genes between H3K4me3 and H3K4me1 in ChIP-Seq. These matched genes were compared with the genes found in RNA-Seq, and theoverlapping and non-overlapping genes were obtained. All overlapping genes and all non-overlapping genes in ChIP-Seq were found in the reference. Nonetheless, a number of non-overlapping genes in RNA-Seq were not found in the reference. We verified a number of genes that were not located in the reference using the Entrez Gene website and the results are shown as described in Experiment 1. All comparison results are in [Table 1](#t1-grsb-8-2014-033){ref-type="table"} and [Figure 3](#f3-grsb-8-2014-033){ref-type="fig"}. All novel genes found are included in [Additional file 3.xls](#s3-grsb-8-2014-033){ref-type="supplementary-material"}.

This experiment implemented the co-localization between promoter H3K4me3 and enhancer H3K4me1 to get the overlapping genes expressed strongly by both promoter and enhancer. We observed the number of matched genes dropped by nearly half compared to the number of promoter or enhancer genes alone. However, the expression level of these genes is stronger. We compared these matched genes with the genes found in RNA-Seq using average FPKM filter and obtained a list of overlapping genes. This overlapping genes list is smaller than the overlapping genes list found in Experiment 1 using Filter 1 because of co-localization. However, it contains even more highly expressed genes. We consistently observed the trend that the more we filtered, the fewer genes we obtained but the more strongly expressed they were.

Experiment 3
------------

As in Experiment 1, we compared the genes found from ChIP-Seq with the genes found from RNA-Seq to obtain the overlapping and non-overlapping genes. All overlapping genes and all non-overlapping genes in ChIP-Seq were found in the reference. However, a number of non-overlapping genes in RNA-Seq were not found in the reference. We also verified a number of genes that were not located in the reference using the Entrez Gene website. The results are shown as described in Experiment 1. All comparison results are in [Table 1](#t1-grsb-8-2014-033){ref-type="table"}. All the genes that are not found in the Ensemble gene reference are included in [Additional file 3.xls](#s3-grsb-8-2014-033){ref-type="supplementary-material"}.

We acquired the nearby genes from ChIP-Seq using 500 bp distance from the start of the peak to the TSS. These are the genes expressed by promoter H3K4me3. We also obtained 75% of the genes from RNA-Seq by sorting FPKM value in descending order. The overlapping genes are those expressed and having promoter H3K4me3 supporting their expression, but they are not all strongly expressed. This overlapping number comparing to the overlapping number from Experiment 1 using Filter 3 does not differ a lot. This indicates that the numbers of nearby genes expressed using the distance of 2 kb or 500 bp are quite similar. Hence, it confirms that most promoters are located in a distance about 2 kb or less to the TSS. The non-overlapping genes in ChIP-Seq but not found in RNA-Seq are not expressed genes or their expression level is not considerable, though their promoters bear H3K4me3 modification. The non-overlapping genes in RNA-Seq but not found in ChIP-Seq are expressed genes but not for histone H3K4me3.

Experiment 4 co-localization
----------------------------

As in Experiment 2, we obtained the matched genes between H3K4me3 and H3K4me1 in ChIP-Seq. These matched genes were compared with the genes found in RNA-Seq for obtaining overlapping and non-overlapping genes. Again, all overlapping genes and non-overlapping genes in ChIP-Seq were confirmed in the reference. However, a number of non-overlapping genes in RNA-Seq were not found in the reference. We also verified a number of genes that were not located in the reference using the Entrez Gene website and the results are shown as reported in Experiment 1. All comparison results are in [Table 1](#t1-grsb-8-2014-033){ref-type="table"} and [Figure 4](#f4-grsb-8-2014-033){ref-type="fig"}. All novel genes found are included in [Additional file 3.xls](#s3-grsb-8-2014-033){ref-type="supplementary-material"}.

This experiment implemented the co-localization between promoter H3K4me3 and enhancer H3K4me1 to get the matched genes expressed strongly by both marks. We observed the number of matched genes dropped less than a half compared to the numbers of the promoter or enhancer genes list alone. However, the expression level of the gene is even stronger. We compared these matched genes with the genes found in RNA-Seq using average FPKM filter to get the overlapping genes. The number of overlapping genes found in this experiment is slightly smaller than the number of overlapping genes found in Experiment 2 because we used a shorter distance of 500 bp to get the nearby genes. The size of the overlapping genes list reduces but it contains more highly expressed genes. Again, we observed the trend that the more we filtered, the fewer genes we acquired but the more strongly expressed they were. This was a consistent result obtained across our experiments.

Again, to visualize the difference between gene expression and correlation, we included two snapshots of UCSC genome browser[@b28-grsb-8-2014-033] views of ChIP-Seq and RNA-Seq data in Figures 6 and 7, which can be found in [Additional Figure 6](#s9-grsb-8-2014-033){ref-type="supplementary-material"} and [Additional Figure 7](#s10-grsb-8-2014-033){ref-type="supplementary-material"}. [Additional Figure 6](#s9-grsb-8-2014-033){ref-type="supplementary-material"} shows the gene *Fabp*1 (fatty acid binding protein 1, liver) and [Additional Figure 7](#s10-grsb-8-2014-033){ref-type="supplementary-material"} shows the gene *Azgp*1 (alpha-2-glycoprotein 1, zinc). Both figures contain three tracks (RNA-Seq liver, ChIP-Seq H3K4me3 liver, and ChIP-Seq H3K4me1 liver). The heights of the peaks in these tracks are very different in both figures, which shows the difference of gene expression in ChIP-Seq and RNA-Seq data for gene *Fabp*1 and gene *Azgp*1. Again, the correlation in this case is the corresponding expression found in both ChIP-Seq and RNA-Seq data for these genes.

GO enrichment comparison for Experiments 1--4
---------------------------------------------

We performed the GOStat analysis for all overlapping genes found in Experiments 1--4.[@b26-grsb-8-2014-033] We observed all the GO enrichment by GO terms and *P*-values in ascending order. It showed that the GO enrichment for overlapping genes in Experiment 4 is the same as the GO enrichment for the overlapping genes in Experiment 2. The reason is that the overlapping genes found from these two experiments are almost identical and their quantities are very close to each other. In fact, they both have the same number of GO terms and *P*-values. Thus, their GO enrichments are similar. We also found the GO enrichment in Experiment 4 and the GO enrichment in Experiment 2 are contained in the GO enrichment of overlapping genes found in Experiment 1 using Filter 1. In addition, the GO enrichment in Experiment 1 using Filter 1 has more GO terms with bigger *P*-values. The GO enrichment in Experiment 1 using Filter 1 is contained in the GO enrichment of the overlapping genes found in Experiment 3 using Filter 3. Also, the GO enrichment in Experiment 3 using Filter 3 has more GO terms with larger *P*-values. Further, the GO enrichment in Experiment 3 using Filter 3 is contained in the GO enrichment of the overlapping genes found in Experiment 1 using Filter 3 and it is also contained in the GO enrichment of the overlapping genes found in Experiment 1 using Filter 2. However, the GO enrichment in Experiment 1 using Filter 3 and the GO enrichment in Experiment 1 using Filter 2 are identical but they have more GO terms with larger *P*-values. [Figure 2](#f2-grsb-8-2014-033){ref-type="fig"} demonstrates the GO enrichment level for each experiment. To sum up, we observed that the more filters we applied, the less overlapping genes we obtained, but the level of GO enrichment went up because it contained highly expressed genes. This trend is expected if the filter criteria go higher.

In Experiment 1, we used three different filters to select highly expressed genes by promoter H3K4me3 with the distance ≤2 kb from the start of the peak to the TSS. In Experiment 3, we reduced the distance from ≤2 kb to ≤500 bp, and used Filter 3 for selecting strongly expressed genes by promoter H3K4me3. However, the overlapping genes result was comparable to the overlapping genes result from Experiment 1 using Filter 3. Nevertheless, it confirmed the fact that most promoters are located in the distance ≤2 kb to the TSS. These highly expressed genes found by promoter H3K4me3 are included in [Additional file 1.xls](#s1-grsb-8-2014-033){ref-type="supplementary-material"}. In Experiment 2, we selected highly expressed genes by both promoter H3K4me3 and enhancer H3K4me1 using the distance ≤2 kb from the start of the peak to the TSS plus applying Filter 1. To get more strongly expressed genes for both marks H3K4me3 and H3K4me1, we reduced the distance from ≤2 kb to ≤500 bp and used Filter 1 in Experiment 4. Thus, we obtained a list of more strongly expressed genes by both marks H3K4me3 and H3K4me1. These highly expressed genes found by both marks are included in [Additional file 2.xls](#s2-grsb-8-2014-033){ref-type="supplementary-material"}. However, these two histone marks do not always characterize highly active genes, because of the fact that there are a number of non-overlapping, very active genes found in RNA-Seq but not found in ChIP-Seq. These genes possess large FPKM values but they are not for histone H3K4me3 or for both histones H3K4me3 and H3K4me1.

Experiment 5
------------

We compared the genes found in ChIP-Seq for H3K4me1 in mouse liver with the genes found in ChIP-Seq for H3K4me1 in mESC to obtain the overlapping and non-overlapping genes. All comparison results are in [Table 1](#t1-grsb-8-2014-033){ref-type="table"}. Some GOStat results can be found in [Tables 4--5 in Supplemental Tables.doc](#s7-grsb-8-2014-033){ref-type="supplementary-material"}.[@b26-grsb-8-2014-033]

The overlapping genes are genes expressed by enhancer H3K4me1 and they have common functions in both liver and embryonic stem cells. Some common functions in GO terms include actin filament-based process and mammary gland morphogenesis, with GO IDs GO:0030029 and GO:0060443 respectively.[@b27-grsb-8-2014-033] The detailed definitions of these GO terms can be found on Gene Ontology website using the GO IDs.[@b27-grsb-8-2014-033] The non-overlapping genes found in H3K4me1 liver but not found in H3K4me1 mESC are genes that carry liver functions, although some still have functions related to the embryonic stem cell. Some functions in GO terms for these non-overlapping genes in liver are included in [Table 4 in Supplemental Tables.doc](#s7-grsb-8-2014-033){ref-type="supplementary-material"}. There are 10,623 genes found for H3K4me1 in liver and only 3,125 genes found for H3K4me1 in mESC. This indicates a large number of genes expressed by enhancer H3K4me1 that carry liver functions, compared to a smaller number of genes that carry mESC functions. The non-overlapping genes found in H3K4me1 in mESC but not found in H3K4me1 in liver are genes performing stem cell functions, although some have liver-related functions. Some functions in GO terms for these non-overlapping genes in mESC are included in [Table 5 in Supplemental Tables.doc](#s7-grsb-8-2014-033){ref-type="supplementary-material"}. Again, the detailed definitions can be looked up on Gene Ontology website using their GO IDs.[@b27-grsb-8-2014-033]

Experiment 6
------------

As in Experiment 5, we compared the genes found in ChIP-Seq for H3K4me3 in mouse liver with the genes found in ChIP-Seq for H3K4me3 in mESC to obtain the overlapping and non-overlapping genes. All comparison results are in [Table 1](#t1-grsb-8-2014-033){ref-type="table"}. Some GOStat results can be found in [Tables 6--7 in Supplemental Tables.doc](#s7-grsb-8-2014-033){ref-type="supplementary-material"}.[@b26-grsb-8-2014-033]

The overlapping genes are genes expressed by promoter H3K4me3 and with common functions in both liver and embryonic stem cells. Some common functions in GO terms include nitrogen compound metabolic process, morphogenesis of a branching epithelium, and establishment of organelle localization, with GO IDs GO:0006807, GO:0061138, and GO:0051656 respectively.[@b27-grsb-8-2014-033] The complete definitions of these GO terms can be found on Gene Ontology website using the GO IDs.[@b27-grsb-8-2014-033] There is a large number of overlapping genes as most of them were found in both liver and mESC. This indicates there are many genes expressed by promoter H3K4me3 that carry common functions between liver and embryonic stem cell. The non-overlapping genes found in H3K4me3 in liver but not found in H3K4me3 in mESC are genes carrying liver functions, although some still carry functions related to the embryonic stem cell. Some functions in GO terms for these non-overlapping genes in liver are included in [Table 6 in Supplemental Tables.doc](#s7-grsb-8-2014-033){ref-type="supplementary-material"}. The non-overlapping genes found in H3K4me3 in mESC but not found in H3K4me3 in liver are genes performing stem cell functions, although some carry liver-related functions. Some functions in GO terms for these non-overlapping genes in mESC are included in [Table 7 in Supplemental Tables.doc](#s7-grsb-8-2014-033){ref-type="supplementary-material"}.

Experiment 7
------------

We compared the genes in RNA-Seq for liver with the genes in RNA-Seq for mESC to obtain the overlapping genes in both tissues and non-overlapping genes in each tissue. The non-overlapping genes in liver are those expressed for liver while the non-overlapping genes in mESC are those expressed for mESC. These genes are included in [Additional file 5.xls](#s5-grsb-8-2014-033){ref-type="supplementary-material"} and [Additional file 6.xls](#s6-grsb-8-2014-033){ref-type="supplementary-material"}, for liver and for mESC respectively. The comparison results are in [Table 1](#t1-grsb-8-2014-033){ref-type="table"}. We found a number of genes in mESC that are not currently in the Ensemble gene reference. Most of these genes are found in the list of novel genes in RNA-Seq for liver, except for a few in RNA-Seq for mESC. These genes are included in the [Additional file 4.xls](#s4-grsb-8-2014-033){ref-type="supplementary-material"}.

[Table 1](#t1-grsb-8-2014-033){ref-type="table"} demonstrates the results obtained in each experiment. Column 2 lists the mark used. Column 3 shows the filter implemented. Column 5 lists the total number of genes acquired for each technique. Column 6 shows the number of overlapping genes obtained. Column 7 shows the overlapping percentage for each technique. Column 8 lists the number of non-overlapping genes found. Columns 9 and 10 show the number genes found in the Ensemble gene reference and the number of genes that were not found in the Ensemble gene reference respectively.

Comparing results between experiments
-------------------------------------

We performed comparisons on the results obtained from different experiments for three cases.

### Case 1: compare matched genes between Experiment 1 and Experiment 2

Let ***A*** = matched genes in Experiment 1 using Filter 1. This matched genes list contains 7,632 genes.

Let ***B*** = matched genes in Experiment 2. This matched genes list contains 4,562 genes.

We investigated whether or not ***A*** is less than ***B*** in terms of average FPKM value. Our calculation shows the average FPKM for ***A*** is 15.44 while the average FPKM for ***B*** is 20.42. Thus, ***A*** indeed is less than ***B***, which means genes in ***B*** are more stongly expressed than genes in ***A***. Again, it consistently confirms that the more overlapping genes are filtered, the more highly expressed are the genes obtained.

### Case 2: compare GOStat in Experiment 5

We compared the GOStat of unmatched genes found in Experiment 5.[@b26-grsb-8-2014-033]

Let ***B*** = GOStat of unmatched genes in H3K4me1 in liver but not found in H3K4me1 in mESC.

Let ***C*** = GOStat of unmatched genes in H3K4me1 in mESC but not found in H3K4me1 in liver.

We inquired whether ***C*** shows liver-related functions. To answer this question, we developed a list of 24 keywords related to liver functions,[@b32-grsb-8-2014-033] shown in [Table 2](#t2-grsb-8-2014-033){ref-type="table"}, and used these keywords as wild cards in the criteria for a query to find liver-related functions in ***C***. Our GOStat results show that ***C*** indeed has some liver-related functions.[@b26-grsb-8-2014-033] Most of these functions involve metabolic processes of different activities, such as regulation of phosphorus metabolic process, regulation of purine nucleotide metabolic process, regulation of primary metabolic process, and so on. The GOStat results for this finding are in [Table 8 in Supplemental Tables.doc](#s7-grsb-8-2014-033){ref-type="supplementary-material"}.[@b26-grsb-8-2014-033] We also used the keyword *embryo* as a wild card in the criteria for a query to find embryonic stem cell-related function in ***B***. The GOStat results also show ***B*** has some embryonic stem cell-related functions.[@b26-grsb-8-2014-033] These functions involve the development of the embryo, such as chordate embryonic development and embryonic morphogenesis. The GOStat results for this finding are in [Table 9 in Supplemental Tables.doc](#s7-grsb-8-2014-033){ref-type="supplementary-material"}.[@b26-grsb-8-2014-033] Thus, the findings show the liver still carries embryonic stem cell-related functions and the embryonic stem cell also carries liver-related functions.

### Case 3: compare GOStat in Experiment 6

We also compared the GOStat of unmatched genes found in Experiment 6.[@b26-grsb-8-2014-033]

Let ***B*** = GOStat of unmatched genes in H3K4me3 in liver but not found in H3K4me3 in mESC.

Let ***C*** = GOStat of unmatched genes in H3K4me3 in mESC but not found in H3K4me3 in liver.

We inquired whether ***C*** shows liver-related functions. We used the list of keywords in [Table 2](#t2-grsb-8-2014-033){ref-type="table"} as wild cards in the criteria for a query to find liver-related function in ***C***. Again, the GOStat results show ***C*** has some liver-related functions, and most of these functions involve metabolic processes of different activities, as described above.[@b26-grsb-8-2014-033] The results for this finding are in [Table 10 in Supplemental Tables.doc](#s7-grsb-8-2014-033){ref-type="supplementary-material"}. We also used the keyword *embryo* for embryonic stem cell-related functions as a wild card in the criteria for a query to find embryonic stem cell-related function in ***B***. The GOStat results also show ***B*** has some embryonic stem cell functions related to ***C*** and these functions involve the embryonic development as described above.[@b26-grsb-8-2014-033] The results for this finding are in [Table 11 in Supplemental Tables.doc](#s7-grsb-8-2014-033){ref-type="supplementary-material"}. Thus, the findings again confirm the liver still carries embryonic stem cell-related functions while the embryonic stem cell also carries liver-related functions.

The comparison results from case 1 again confirm that the filters we apply, the less overlapping genes we acquire, but they are more highly expressed genes. In addition, co-localization resulted in less overlapping genes but stronger expression. The comparison results from case 2 and case 3 reveal liver carries embryonic stem cell functions while embryonic stem cell carries liver-related functions.

Conclusions
===========

We performed four experiments involving gene comparison for mouse liver between Chip-Seq and RNA-Seq. We identified highly expressed genes by histone H3K4me3 or by both histones H3K4me3 and H3K4me1 by performing three essential steps. First, we identified the expressed genes in ChIP-Seq by using different filters on the distance from the start of the peak to the TSS. Second, we identified expressed genes in RNA-Seq by implementing different filters on FPKM value. Third, we compared the expressed genes in ChIP-Seq with the expressed genes in RNA-Seq and selected highly expressed genes by both ChIP-Seq and RNA-Seq. These highly expressed genes for histone H3K4me3 or for both histones H3K4me3 and H3K4me1 are included in [Additional file 1.xls](#s1-grsb-8-2014-033){ref-type="supplementary-material"} and [Additional file 2.xls](#s2-grsb-8-2014-033){ref-type="supplementary-material"} respectively. In addition, we performed two experiments copmrising gene comparison between mouse liver and mESC for histone H3K4me3 and for histone H3K4me1 using Chip-Seq. We compared the expressed genes in mouse liver with the expressed genes in mESC and performed the GOStat analysis on the overlapping genes in both tissues and on the non-overlapping genes for each tissue.[@b26-grsb-8-2014-033] The GOStat results revealed that in mice,[@b26-grsb-8-2014-033] the liver carries embryonic stem cell-related functions, while the embryonic stem cell also carries liver-related functions. Most of the embryonic stem cell-related functions carried by the liver involve embryonic development, while the liver-related functions carried by mESC involve metabolic processes of different activities. We verified the overlapping genes and non-overlapping genes from ChIP-Seq and RNA-Seq with the public Ensemble gene database from NCBI. Our analysis uncovered a number of expressed genes that are not currently in the Ensemble gene reference. These genes are in RNA-Seq for mouse liver. We verified a number of these genes on the Entrez Gene website from NCBI and the results showed they are novel genes, which have reference sequence status of validated, predicted, provisional, or inferred. These genes are also included in [Additional file 3.xls](#s3-grsb-8-2014-033){ref-type="supplementary-material"}. Further, we identified the expressed genes for liver and the expressed genes for mESC by comparing genes in RNA-Seq for liver with genes in RNA-Seq for mESC. These genes are included in [Additional file 5.xls](#s5-grsb-8-2014-033){ref-type="supplementary-material"} and [Additional file 6.xls](#s6-grsb-8-2014-033){ref-type="supplementary-material"} for liver and for mESC respectively. Lastly, we identified a number of genes in RNA-Seq for mESC that are not presently in the Ensemble gene reference. Most of them are found in the list of novel genes in RNA-Seq for liver, except for a few that are in RNA-Seq for mESC only. These novel genes are included in [Additional file 4.xls](#s4-grsb-8-2014-033){ref-type="supplementary-material"}.
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Highly expressed genes by H3K4me3 and H3K4me1
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[Tables 3--11](#s7-grsb-8-2014-033){ref-type="supplementary-material"}
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UCSC genome browser view of ChIP-Seq and RNA-Seq data for mouse liver. The height of the peaks in the tracks shows the difference of gene expression. The tracks show the correlation of gene expression in ChIP-Seq and RNA-Seq data for gene symbol *Slc*25*a*47.

###### 

UCSC genome browser view of ChIP-Seq and RNA-Seq data for mouse liver. The height of the peaks in the tracks shows the difference of gene expression. The tracks show the correlation of gene expression in ChIP-Seq and RNA-Seq data for gene symbol *Fabp*1.

###### 

UCSC genome browser view of ChIP-Seq and RNA-Seq data for mouse liver. The height of the peaks in the tracks shows the difference of gene expression. The tracks show the correlation of gene expression in ChIP-Seq and RNA-Seq data for gene symbol *Azgp*1.
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![Workflow depicts general steps of the analysis using ChIP-Seq and RNA-Seq.](grsb-8-2014-033f1){#f1-grsb-8-2014-033}

![GO enrichment analysis for overlapping genes in Experiment 1 through Experiment 4. The GO enrichment level increases toward inner circle. The innermost circle has the highest GO enrichment level.](grsb-8-2014-033f2){#f2-grsb-8-2014-033}

![Overlapping and non-overlapping genes from co-localization between ChIP-Seq for H3K4me3 and ChIP-Seq for H3K4me1 in Experiment 2.](grsb-8-2014-033f3){#f3-grsb-8-2014-033}

![Overlapping and non-overlapping genes from co-localization between ChIP-Seq for H3K4me3 and ChIP-Seq for H3K4me1 in Experiment 4.](grsb-8-2014-033f4){#f4-grsb-8-2014-033}

###### 

Summary of all experimental results.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  EXPERIMENT \#                      MARK                            FILTER                          TECHNIQUE   \# OF GENES   \# OF OVERLAPPED GENES   \% OVERLAPPED   \# OF NON-OVERLAPPED GENES   \# OF GENES FOUND IN REF.   \# OF GENES NOT FOUND IN REF.
  ---------------------------------- ------------------------------- ------------------------------- ----------- ------------- ------------------------ --------------- ---------------------------- --------------------------- -------------------------------
  1                                  H3K4me3                         Average FPKM                    RNA-Seq     9407          7632                     81%             1775                         9214                        193

  2 kb nearby genes                  ChIP-Seq                        12382                           7632        62%           4750                     12382           0                                                        

  H3K4me3                            All FPKM                        RNA-Seq                         23235       12004         52%                      11231           21821                        1414                        

  2 kb nearby genes                  ChIP-Seq                        12382                           12004       97%           378                      12004           0                                                        

  H3K4me3                            3/4 FPKM sorted Descending      RNA-Seq                         15599       11062         71%                      4537            15073                        526                         

  2 kb nearby genes                  ChIP-Seq                        12382                           11062       89%           1320                     12382           0                                                        

  2 (co-localization)                H3K4me3 & H3K4me1               Average FPKM                    RNA-Seq     9407          4562                     48%             4845                         9214                        193

  2 kb nearby genes for H3K4me3\     ChIP-Seq                        6674                            4562        68%           2112                     6674            0                                                        
  1 Mb nearby genes for H3K4me1                                                                                                                                                                                                  

  3                                  H3K4me3                         3/4 FPKM sorted Descending      RNA-Seq     15599         10975                    70%             4624                         15073                       526

  500 bp nearby genes                ChIP-Seq                        12192                           10975       90%           1217                     12192           0                                                        

  4 (co-localization)                H3K4me3 & H3K4me1               Average FPKM                    RNA-Seq     9407          4536                     48%             4871                         9214                        193

  500 bp nearby genes for H3K4me3\   ChIP-Seq                        6549                            4536        69%           2013                     6549            0                                                        
  1 Mb nearby genes for H3K4me1                                                                                                                                                                                                  

  5                                  H3K4me1 for mESC                1 Mb nearby genes for H3K4me1   ChIP-Seq    3125          2104                     67%             1021                         N/A                         N/A

  H3K4me1 for Liver                  1 Mb nearby genes for H3K4me1   ChIP-Seq                        10623       2104          20%                      8519            N/A                          N/A                         

  6                                  H3K4me3 for mESC                2 kb nearby genes               ChIP-Seq    10988         10250                    93%             738                          N/A                         N/A

  H3K4me3 for Liver                  2 kb nearby genes               ChIP-Seq                        12382       10250         83%                      2132            N/A                          N/A                         

  7                                  mESC                            All FPKM                        RNA-Seq     23241         23206                    99.8 4%         35                           21827                       1414

  Liver                              All FPKM                        RNA-Seq                         23235       23206         99.87%                   29              21821                        1414                        
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Keywords related to liver.

  ---------------- ------------- ------------ --------- ----------------
  albumin          biliru        diges        hormone   plasma
  ammonia          carbohy       emulsifi     insulin   protein
  angiotensi       cholesterol   gluco        lipid     red blood cell
  bile             toxi          hemoglo      metabo    retinoid
  thrombopoietin   toxic         triglyceri   fat       
  ---------------- ------------- ------------ --------- ----------------
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